Jyong Biotech Ltd (MENS)

Jul 21, 2025

Jyong Biotech Ltd.’s Quiet Period Set To Expire on July 28th (NASDAQ:MENS) - Defense World

Jul 21, 2025

Jul 03, 2025

Jyong Biotech shares rise 3.85% in premarket after rating upgrade and CEO's Nasdaq bell ringing. - AInvest

Jul 03, 2025

Jul 02, 2025

Yong Biotech Ltd (Nasdaq:MENS) Marks Milestone at Nasdaq Composite MarketSite - Kalkine Media

Jul 02, 2025

Jul 02, 2025

Jyong Biotech Ltd. Rings the Closing Bell - Nasdaq

Jul 02, 2025

Jul 01, 2025

Jyong Biotech shares fall 10.24% in premarket after recent gains following Nasdaq listing. - AInvest

Jul 01, 2025

Jun 30, 2025

Jyong Biotech shares fall 4.92% in after-hours following a 34.80% surge post-Nasdaq listing and 11.04% gain over the past five days. - AInvest

Jun 30, 2025

Jun 27, 2025

Jyong Biotech shares rise 2.11% intraday as biotech sector gains and company completes $20M IPO. - AInvest

Jun 27, 2025

Jun 26, 2025

Jyong Biotech shares rise 11.82% intraday after successful $20 million IPO and addition to Nasdaq Composite Index. - AInvest

Jun 26, 2025

Jun 24, 2025

Jyong’s $20M US IPO to help refile NDA of urological botanic drug - BioWorld MedTech

Jun 24, 2025

Jun 20, 2025

Jyong Biotech Soars 11.13% Post $20M IPO - AInvest

Jun 20, 2025

Jun 19, 2025

MENSJyong Biotech Ltd. Latest Stock News & Market Updates - Stock Titan

Jun 19, 2025

Jun 18, 2025

Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Jun 18, 2025

Jun 17, 2025

Jyong Biotech Ltd. IPO opens at $15 after pricing at $7.50 per share - Investing.com Nigeria

Jun 17, 2025

Jun 16, 2025

Jyong Biotech Ltd. Announces Pricing of $20 Million Initial Public Offering - GlobeNewswire

Jun 16, 2025

Feb 10, 2025

Jyong Biotech Seeks US IPO On Thin Capitalization And Uphill Regulatory Battle (MENS) - Seeking Alpha

Feb 10, 2025

Feb 06, 2025

MENS IPO NewsUrinary disease biotech Jyong Biotech sets terms for $19 million US IPO - renaissancecapital.com

Feb 06, 2025

Mar 07, 2024

Commercial-ready Taiwanese biotech developing therapies for urinary diseases. - renaissancecapital.com

Mar 07, 2024

Dec 20, 2023

JYB IPO NewsUrinary disease biotech Jyong Biotech withdraws $40 million US IPO - renaissancecapital.com

Dec 20, 2023

Aug 18, 2023

Jyong Biotech Ltd. Begins U.S. IPO Rollout (Pending:JYB) - Seeking Alpha

Aug 18, 2023

Nov 30, 2022

Laxton Investments Company Ltd. v. Jyong Biotech Ltd. et al: Originating Summons - OffshoreAlert

Nov 30, 2022